Abstract | INTRODUCTION: CASE REPORTS: Case one: A 43-year-old woman presented to the emergency department two hours after ingesting 100 tablets of 7.5 mg zopiclone. Her initial vital signs, physical examination, chest x-ray, and electrocardiogram were normal. Two hours post-ingestion her methemoglobin level was 9.8%; 14 hours post-arrival she showed cyanosis of the lips and extremities and dyspnea after walking. The blood sample 16 hours post-ingestion was dark brown in color and the methemoglobin was 23.8%. Shortly after the second of two doses of methylene blue (1 mg/kg each) her methemoglobin was 3.6%. Case two: A 30-year-old woman came to the emergency department 50 hours after ingesting 150 to 200 tablets of 7.5 mg zopiclone. Her vital signs and physical examination were normal. Her methemoglobin level was 5.2% at 52 hours post-ingestion and it peaked at 10.4% one hour later. She recovered following symptomatic care. DISCUSSION AND CONCLUSIONS:
Methemoglobinemia has not previously been reported following acute zopiclone overdose. In our patients, there were no identifiable alternative causes explaining the methemoglobinemia and zopiclone was confirmed in both patients by laboratory analysis. These two cases suggest that zopiclone overdose is capable of producing delayed methemoglobinemia, which may be related to formation of a sufficient quantity of the N- oxide metabolite.
|
Authors | Hin Tat Fung, Cing Hon Lai, Oi Fung Wong, Ka Keung Lam, Chak Wah Kam |
Journal | Clinical toxicology (Philadelphia, Pa.)
(Clin Toxicol (Phila))
Vol. 46
Issue 2
Pg. 167-70
(Feb 2008)
ISSN: 1556-3650 [Print] England |
PMID | 18259966
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Azabicyclo Compounds
- Enzyme Inhibitors
- Hypnotics and Sedatives
- Piperazines
- Tablets
- zopiclone
- zopiclone N-oxide
- N-desmethylzopiclone
- Methylene Blue
|
Topics |
- Adult
- Azabicyclo Compounds
(administration & dosage, adverse effects, chemistry)
- Drug Overdose
- Enzyme Inhibitors
(therapeutic use)
- Female
- Humans
- Hypnotics and Sedatives
(administration & dosage, adverse effects, chemistry)
- Methemoglobinemia
(chemically induced, complications, prevention & control)
- Methylene Blue
(therapeutic use)
- Molecular Structure
- Piperazines
(administration & dosage, adverse effects, chemistry)
- Tablets
|